Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin in Persistent or Recurrent Cervical Cancer
NCT00030472Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Dec 2001
- Primary completion
- Oct 2006
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 2
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in Cervical Cancer (CC), sponsored by GOG Foundation. Started Dec 2001; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00030472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030472.